Skip to main content

Rigel Pharmaceuticals Inc 10-Q for FY2025 Q1

Rigel Pharmaceuticals Inc (RIGL)

10-Q 2025-05-06 For: 2025-03-31
View Original
Added on April 06, 2026

About this 10-Q

Rigel Pharmaceuticals Inc filed this 10-Q on May 6, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).

Headline figures

Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$53.33M
up 80.6% from $29.53M a year earlier
Net income
$11.45M
compared with a net loss of $8.25M a year earlier
Diluted EPS
$0.63
compared with -$0.47 a year earlier